Could Be The Biggest Suppliers in the Hemp-derived Product Market
From Kim Kardashian actually hosting a hemp product themed baby shower to Dr. Oz and Sanjay Gupta consistently singing its praises – few things are hotter right now than hemp-derived product.
According to a feature by E! Hollywood Kim K wanted her friends & family to “zen out on a Saturday” at the event, noting the benefits of hemp-derived product to actively ease anxiety and other ailments without any psychoactive properties.
Actor Seth Rogen is so convinced of the benefits of hemp-derived product for those with Alzheimer’s that he testified before Congress on those benefits.
Golf pro Bubba Watson uses this magical chemical compound to recover after a long day of golf. He told Fox Business’s Gerri Willis, “I’m a believer in it, I’ve been using it”.
These are just a couple of the A-list celebrities and athletes on a long and growing list that are calling attention to the benefits of hemp-derived product.
In fact, hemp-derived product has gone viral and it’s only the beginning. The market is forecast to grow at a rate of 36X … from $600 million last year to $22 billion by 2022.
Enter StillCanna (CSE:STIL) (OTC:SCNNF), a new entrant in this rapidly growing market with an opening price of $1.00, just completed an oversubscribed $24.36 million private placement.
On May 7th, StillCanna, (CSE:STIL) (OTC:SCNNF) acquired 100% of Polish hemp producer, Olimax. This acquisition providers Stillcanna with a vertically integrated licensed cultivator, extractor and formulator of hemp-derived products. One of Olimax’s many core strengths is their agricultural expertise with hemp.